IOR is proud to present his latest Group Leader

news on 18 Feb , 2019

The Institute of Oncology Research is proud to announce the designation of a new Group Leader: Dr. Arianna Calcinotto.

Dr. Calcinotto obtained a PhD in Molecular Medicine with honors (Università Vita-Salute San Raffaele, Milan, IT) in 2015. During her PhD she spent a period in the laboratory of Leif Bergsagel (Mayo Clinic, Scottsdale, AZ, US).

During these years, she has developed an extensive knowledge and experience on cancer immunology. In particular, she studied cancer cell-immune cell interactions in the tumor microenvironment during different phases of cancer development and progression in both solid tumors and hematological malignancies developing novel immunotherapies for cancer.

Dr. Calcinotto did postdoctoral work at the Institute of Oncology Research IOR with Prof. Andrea Alimonti, where she described for the first time how an immune cell population can directly fuel the proliferation of prostate cancer cells.

As of 2019, Arianna Calcinotto has published >20 articles in peer-reviewed journals, including papers as first author in Nature and Nature communications.

Starting July 2019, Dr. Calcinotto will take the lead of the newly born Cancer Immunotherapy Lab at IOR.

The main research objective of the Cancer Immunotherapy Group is unraveling the multiple non-cell autonomous aspects of disease progression and therapy resistance dictated by immune cells in breast tumors and their contribution to genomic instability and cancer susceptibility.